ID   ABC03
AC   CVCL_C8MW
SY   2G7
DR   Wikidata; Q123030381
RX   Patent=CN112375745B;
RX   PubMed=33502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19176.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI:149836; Tigecycline (Tygacil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=CN112375745B;
RA   Xu C.-L., Lu Q.-Q., Kuang H., Xu L.-G., Sun M.-Z., Liu L.-Q.,
RA   Song S.-S., Wu X.-L., Hao C.-L., Hu Y.-M.;
RT   "Hybridoma cell line secreting tigecycline monoclonal antibody and
RT   application thereof.";
RL   Patent number CN112375745B, 15-Mar-2022.
//
RX   PubMed=33502396; DOI=10.1039/d0ay02182b;
RA   Lu Q.-Q., Xu X.-X., Song S.-S., Wu A.-H., Liu L.-Q., Kuang H.,
RA   Xu C.-L.;
RT   "Development of a monoclonal antibody-based immunochromatographic
RT   strip for the rapid detection of tigecycline in human serum.";
RL   Anal. Methods 13:817-824(2021).
//